Journal Home > Volume 12 , Issue 6

Xylitol and erythritol have been reported in numerous previous and recent studies as potential antidiabetic sweeteners, however, it is not certain which one is most effective in this regard. In the present study, the effects of xylitol and erythritol were comparatively investigated on blood glucose, insulin level, dyslipidemia, pancreatic islet morphology and β-cell function, and redox imbalance in a type 2 diabetes (T2D) model of rats. Seven-week-old male Sprague-Dawley rats were randomly divided into 8 groups: Normal Control (NC), Diabetic Control (DC), Diabetic Xylitol 5% (DX5), Diabetic Xylitol 10% (DX10), Diabetic Xylitol 20% (DX20), Diabetic Erythritol 5% (DE5), Diabetic Erythritol 10% (DE10), and Diabetic Erythritol 20% (DE20). T2D was induced in the diabetic groups initially by feeding 10% fructose solution to induce insulin resistance followed by an intraperitoneal injection of streptozotocin (40 mg/kg body weight) dissolved in citrate buffer (pH 4.5) to induce partial pancreatic β-cells dysfunctions. The animals in NC group were fed with normal drinking water and injected with citrate buffer only. After the confirmation of diabetes, the xylitol and erythritol with above-mentioned concentrations were supplied to the respective animal groups when the animals in NC and DC groups were supplied with normal drinking water. After 8 weeks intervention period, the body weight, fluid and water intake, blood glucose, serum alanine aminotransferase, aspartate aminotransferase, CK-MB and creatinine were significantly decreased, while the serum insulin level, serum lipids, glucose tolerance ability, pancreatic islet morphology and β-cell function, pancreatic and serum redox imbalance were improved in the most xylitol and erythritol fed groups compared to the DC group, when effects were better for xylitol compared to erythritol. The data of this study suggest that xylitol has better antioxidant and antidiabetic effects compared to erythritol. Therefore, xylitol can be used as a preferrable dietary anti-diabetic sweetener or supplement over erythritol for the management of diabetes and its associated complications.


menu
Abstract
Full text
Outline
About this article

Comparative effects of xylitol and erythritol on modulating blood glucose; inducing insulin secretion; reducing dyslipidemia and redox imbalance in a type 2 diabetes rat model

Show Author's information Nontokozo Z. MsomiaOchuko L. Erukainurea,bVeronica F. SalauaKolawole A. OlofinsanaMd. Shahidul Islama( )
Department of Biochemistry, University of KwaZulu-Natal, Westville Campus, Durban 4000, South Africa
Department of Pharmacology, University of the Free State, Bloemfontein 9300, South Africa

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

Xylitol and erythritol have been reported in numerous previous and recent studies as potential antidiabetic sweeteners, however, it is not certain which one is most effective in this regard. In the present study, the effects of xylitol and erythritol were comparatively investigated on blood glucose, insulin level, dyslipidemia, pancreatic islet morphology and β-cell function, and redox imbalance in a type 2 diabetes (T2D) model of rats. Seven-week-old male Sprague-Dawley rats were randomly divided into 8 groups: Normal Control (NC), Diabetic Control (DC), Diabetic Xylitol 5% (DX5), Diabetic Xylitol 10% (DX10), Diabetic Xylitol 20% (DX20), Diabetic Erythritol 5% (DE5), Diabetic Erythritol 10% (DE10), and Diabetic Erythritol 20% (DE20). T2D was induced in the diabetic groups initially by feeding 10% fructose solution to induce insulin resistance followed by an intraperitoneal injection of streptozotocin (40 mg/kg body weight) dissolved in citrate buffer (pH 4.5) to induce partial pancreatic β-cells dysfunctions. The animals in NC group were fed with normal drinking water and injected with citrate buffer only. After the confirmation of diabetes, the xylitol and erythritol with above-mentioned concentrations were supplied to the respective animal groups when the animals in NC and DC groups were supplied with normal drinking water. After 8 weeks intervention period, the body weight, fluid and water intake, blood glucose, serum alanine aminotransferase, aspartate aminotransferase, CK-MB and creatinine were significantly decreased, while the serum insulin level, serum lipids, glucose tolerance ability, pancreatic islet morphology and β-cell function, pancreatic and serum redox imbalance were improved in the most xylitol and erythritol fed groups compared to the DC group, when effects were better for xylitol compared to erythritol. The data of this study suggest that xylitol has better antioxidant and antidiabetic effects compared to erythritol. Therefore, xylitol can be used as a preferrable dietary anti-diabetic sweetener or supplement over erythritol for the management of diabetes and its associated complications.

Keywords: Oxidative stress, Type 2 diabetes, Xylitol, Erythritol, Sweeteners

References(58)

[1]
IDF, IDF diabetes atlas, 9th ed., Brussels, Belgium, 2019.
[2]

P. Saeedi, I. Petersohn, P. Salpea, et al., Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition, Diabetes Res. Clin. Pract. 157 (2019) 1-10. https://doi.org/10.1016/j.diabres.2019.107843.

[3]

H.W. Baynest, Classification, pathophysiology, diagnosis and management of diabetes, J. Diabetes Metab. 6 (2015) 2155-2156. https://doi.org/10.4172/2155-6156.1000541.

[4]

ADA, Classification and diagnosis of diabetes: standards of medical care in diabetes - 2019, Diabetes Care 42 (2019) 13-28. https://doi.org/10.2337/dc19-S002.

[5]

ADA, Diagnosis and classification of diabetes mellitus, Diabetes Care 37 (2014) 81-90. https://doi.org/10.2337/dc14-S081.

[6]

U. Galicia-Garcia, A. Benito-Vicente, S. Jebari, et al., Pathophysiology of type 2 diabetes mellitus, Int. J. Mol. Sci. 21 (2020) 1-34. https://doi.org/10.3390/ijms21176275.

[7]

U. Asmat, K. Abad, K. Ismail, Diabetes mellitus and oxidative stress—a concise review, Saudi Pharm. J. 24 (2016) 547-553. https://doi.org/10.1016/j.jsps.2015.03.013.

[8]
O.R. Ayepola, N.L. Brooks, O.O. Oguntibeju, Oxidative stress and diabetic complications: the role of antioxidant vitamins and flavonoids, in: O. Oguntibeju (Ed.), Antioxidant-Antidiabetic Agents Human Health, InTechOpen, 2014. https://doi.org/10.5772/57282.
DOI
[9]

F. Giacco, M. Brownlee, Oxidative stress and diabetic complications, Circ. Res. 107 (2010) 1058-1070. https://doi.org/10.1161/CIRCRESAHA.110.223545.

[10]

O.M. Ighodaro, Molecular pathways associated with oxidative stress in diabetes mellitus, Biomed. Pharmacother 108 (2018) 656-662. https://doi.org/10.1016/j.biopha.2018.09.058.

[11]

C.G. Awuchi, C.K. Echeta, V.S. Igwe, Diabetes and the nutrition and diets for its prevention and treatment: a systematic review and dietetic perspective, Am. Assoc. Sci. Technol. 6 (2020) 5-19.

[12]

R. Giacco, C. Vetrani, E. Griffo, et al., Role of diet and diet interventions in diabetic patients: physiological and metabolic changes and reduction in morbidity and mortality, Curr. Nutr. Rep. 2 (2013) 174-180. https://doi.org/10.1007/s13668-013-0063-1.

[13]
IDF, IDF framework for action on sugar, Brussels, Belgium, 2014.
[14]
WHO, Guideline: sugars intake for adults and children, Geneva, 2015. https://doi.org/9789241549028.
[15]
SACN, Carbohydrates and health report, England, 2015. https://doi.org/9780117082847.
[16]
USDA, Scientific report of the 2015 dietary guidelines advisory committee, Washington, 2015.
[17]

E. Mejia, M. Pearlman, Natural alternative sweeteners and diabetes management, Curr. Diab. Rep. 19 (2019) 142. https://doi.org/10.1007/s11892-019-1273-8.

[18]
G.A. Blekas, Food additives: classification, uses and regulation, 1st ed., Elsevier Ltd., 2016. https://doi.org/10.1016/B978-0-12-384947-2.00304-4.
DOI
[19]
A. Das, R. Chakraborty, Sweeteners: classification, sensory and health effects, 1st ed., Elsevier Ltd., 2016. https://doi.org/10.1016/B978-0-12-384947-2.00677-2.
DOI
[20]

S. Lohner, I. Toews, J.J. Meerpohl, Health outcomes of non-nutritive sweeteners: analysis of the research landscape, Nutr. J. 16 (2017) 55. https://doi.org/10.1186/s12937-017-0278-x.

[21]

I. Liauchonak, B. Qorri, F. Dawoud, et al., Non-nutritive sweeteners and their implications on the development of metabolic syndrome, Nutrients 11 (2019) 644. https://doi.org/10.3390/nu11030644.

[22]

M.I. Daher, J.M. Matta, A.M. Abdel Nour, Non-nutritive sweeteners and type 2 diabetes: should we ring the bell?, Diabetes Res. Clin. Pract. 155 (2019) 107786. https://doi.org/10.1016/j.diabres.2019.107786.

[23]

M. Grembecka, Sugar alcohols—their role in the modern world of sweeteners: a review, Eur. Food Res. Technol. 241 (2015) 1-14. https://doi.org/10.1007/s00217-015-2437-7.

[24]

C.G. Awuchi, Sugar alcoholes: chemistry, production, health concerns and nutritional importance of mannitol, sorbitol, xylitol and erythritol, Int. J. Adv. Acad. Res. 3 (2017) 31-66.

[25]
T.M.S. Wolever, A. Piekarz, M. Hollands, et al., Sugar alcohols anddiabetes : a review, 26 (2002) 356-362.
[26]

B.K. Wölnerhanssen, A.C. Meyer-Gerspach, C. Beglinger, et al., Metabolic effects of the natural sweeteners xylitol and erythritol: a comprehensive review, Crit. Rev. Food Sci. Nutr. 60 (2020) 1986-1998. https://doi.org/10.1080/10408398.2019.1623757.

[27]

C.I. Chukwuma, R. Mopuri, S. Nagiah, et al., Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats, Eur. J. Nutr. 57 (2018) 2341-2344. https://doi.org/10.1007/s00394-017-1516-x.

[28]

C.I. Chukwuma, M.S. Islam, Effects of xylitol on carbohydrate digesting enzymes activity, intestinal glucose absorption and muscle glucose uptake: a multi-mode study, Food Funct. 6 (2015) 955-962. https://doi.org/10.1039/c4fo00994k.

[29]

E.K. Salminen, S.J. Salminen, L. Porkka, et al., Xylitol vs glucose: effect on the rate of gastric emptying and motilin, insulin, and gastric inhibitory polypeptide release, Am. J. Clin. Nutr. 49 (1989) 1228-1232.

[30]

T. Yokozawa, H.Y. Kim, E.J. Cho, Erythritol attenuates the diabetic oxidative stress through modulating glucose metabolism and lipid peroxidation in streptozotocin-induced diabetic rats, J. Agric. Food Chem. 50 (2002) 5485-5489. https://doi.org/10.1021/jf020168z.

[31]

A.C. Meyer-Gerspach, J. Drewe, W. Verbeure, et al., Effect of the natural sweetener xylitol on gut hormone secretion and gastric emptying in humans: a pilot dose-ranging study, Nutrients 13 (2021) 174. https://doi.org/10.3390/nu13010174.

[32]

K. Amo, H. Arai, T. Uebanso, et al., Effects of xylitol on metabolic parameters and visceral fat accumulation, J. Clin. Biochem. Nutr. 49 (2011) 1-7. https://doi.org/10.316/jcbn.10-111.

[33]

M.S. Islam, Effects of xylitol as a sugar substitute on diabetes-related parameters in nondiabetic rats, J. Med. Food. 14 (2011) 505-511. https://doi.org/10.1089/jmf.2010.0015.

[34]

M.A. Rahman, M.S. Islam, Xylitol improves pancreatic islets morphology to ameliorate type 2 diabetes in rats: a dose response study, J. Food Sci. 79 (2014) 1-7. https://doi.org/10.1111/1750-3841.12520.

[35]

C.I. Chukwuma, S. Islam, Xylitol improves anti-oxidative defense system in serum, liver,heart, kidney and pancreas of normal and type 2 diabetes model of rats, Acta Pol. Pharm. 74 (2017) 817-826.

[36]

B.K. Wölnerhanssen, J. Drewe, W. Verbeure, et al., Gastric emptying of solutions containing the natural sweetener erythritol and effects on gut hormone secretion in humans: a pilot dose-ranging study, Diabetes, Obes. Metab. 13 (2021) 1-21. https://doi.org/10.1111/dom.14342.

[37]

H. Wen, B. Tang, A.J. Stewart, et al., Erythritol attenuates postprandial blood glucose by inhibiting α-glucosidase, J. Agric. Food Chem. 66(6) (2018) 1401-1407. https://doi.org/10.1021/acs.jafc.7b05033.

[38]

D.R. Janero, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radic. Biol. Med. 9 (1990) 515-540.

[39]

G.L. Ellman, K.D. Courtney, V. Andres Jr, et al., A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol. 7 (1961) 88-95.

[40]

P. Gee, A.J. Davison, Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions, Free Radic. Biol. Med. 6 (1989) 271-284.

[41]

H. Aebi, Catalase in vitro, Methods Enzymol. 105 (1984) 121-126.

[42]

P. Kishore, S. Kehlenbrink, M. Hu, et al., Xylitol prevents NEFA-induced insulin resistance in rats, Diabetologia 55 (2012) 1808-1812.

[43]

I.C. Moraes-Silva, C. Mostarda, E.D. Moreira, et al., Preventive role of exercise training in autonomic, hemodynamic, and metabolic parameters in rats under high risk of metabolic syndrome development, J. Appl. Physiol. 114 (2013) 786-791. https://doi.org/10.1152/japplphysiol.00586.2012.

[44]

K.L. Stanhope, J.M. Schwarz, N.L. Keim, et al., Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans, J. Clin. Invest. 119 (2009) 1322-1334. https://doi.org/10.1172/JCI37385.

[45]

S.W. Rizkalla, J. Boillot, V. Tricottet, et al., Effects of chronic dietary fructose with and without copper supplementation on glycaemic control, adiposity, insulin binding to adipocytes and glomerular basement membrane thickness in normal rats, Br. J. Nutr. 70 (1993) 199-209. https://doi.org/10.1079/bjn19930117.

[46]

K.L. Teff, S.S. Elliott, M. Tschöp, et al., Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women, J. Clin. Endocrinol. Metab. 89 (2004) 2963-2972. https://doi.org/10.1210/jc.2003-031855.

[47]

A. Lindqvist, A. Baelemans, C. Erlanson-Albertsson, Effects of sucrose, glucose and fructose on peripheral and central appetite signals, Regul. Pept. 150 (2008) 26-32. https://doi.org/10.1016/j.regpep.2008.06.008.

[48]

A. Shapiro, W. Mu, C. Roncal, et al., Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding, Am. J. Physiol. Regul. Integr. Comp. Physiol. 295 (2008) 1370-1375. https://doi.org/10.1152/ajpregu.00195.2008.

[49]

B.W. Huang, M.T. Chiang, H.T. Yao, et al., The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats, Diabetes, Obes. Metab. 6 (2004) 120-126.

[51]

K. Kaku, Pathophysiology of type 2 diabetes and its treatment policy, Japan Med. Assoc. 53 (2010) 41-46.

[52]

I. Jialal, G. Singh, Management of diabetic dyslipidemia: an update, World J. Diabetes. 10 (2019) 280-290. https://doi.org/10.4239/wjd.v10.i5.280.

[54]

J.M. Forbes, M.E. Cooper, Mechanisms of diabetic complications, Physiol. Rev. Am. J. Physiol. 93 (2013) 137-188. https://doi.org/10.1152/physrev.00045.2011.

[55]

W. Arika, D. Nyamai, K. Osano, et al., Biochemical markers of in vivo hepatotoxicity, J. Clin. Toxicol. 6 (2016) 1-8. https://doi.org/10.4172/2161-0495.1000297.

[56]

N.A.A. Amartey, K. Nsiah, F.O. Mensah, Plasma levels of uric acid, urea and creatinine in diabetics who visit the clinical analysis laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, J. Clin. Diagnostic Res. 9 (2015) 5-9. https://doi.org/10.7860/JCDR/2015/10905.5530.

[57]

R. Fazel, J. Fang, E. Kline-Rogers, et al., Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes, Heart J. 91 (2005) 388-390. https://doi.org/10.1136/hrt.2003.032797.

[58]

P.C. Chikezie, O.A. Ojiako, A.C. Ogbuji, Oxidative stress in diabetes mellitus, Int. J. Biol. Chem. 9 (2015) 92-109. https://doi.org/10.3923/ijbc.2015.92.109.

[60]

G. Pizzino, N. Irrera, M. Cucinotta, et al., Oxidative stress: harms and benefits for human health, Oxid. Med. Cell. Longev. 2017 (2017) 1-14. https://doi.org/10.1155/2017/8416763.

[61]

K.W. Kang, S.H. Kwak, S.Y. Yun, et al., Evaluation of antioxidant activity of sugar alcohols using TOSC (total oxy-radical scavenging capacity) assay, J. Toxicol. Public Heal. 23 (2007) 143-150. https://doi.org/10.5487/TR.2007.23.2.143.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 31 August 2021
Revised: 25 September 2021
Accepted: 03 April 2022
Published: 04 April 2023
Issue date: November 2023

Copyright

© 2023 Beijing Academy of Food Sciences.

Acknowledgements

Acknowledgements

This work was supported by funding from the Research office, University of KwaZulu-Natal, Durban and the National Research Foundation, Pretoria, South Africa (112430).

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return